Atlas Trials

Neoadjuvant Immunochemotherapy for Lung Cancer

Clinical trial NCT06023797 · COMPLETED

Trial details

NCT number
NCT06023797
Sponsor
Shanghai Zhongshan Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Lung Cancer
Start date
2017-01-01
Primary completion
2022-11-01
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.